Johnson & Johnson MedTech Data Sparks Fresh Look At JNJ Valuation [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
Johnson & Johnson (NYSE:JNJ) presented new clinical data on its recently FDA-approved TECNIS PureSee intraocular lens at the 2026 ASCRS meeting. The data highlighted vision outcomes, patient satisfaction, and spectacle independence compared with standard intraocular lens solutions. The update adds clinical detail to earlier regulatory approvals and product announcements in Johnson & Johnson's MedTech portfolio. For investors tracking NYSE:JNJ, this update sits squarely in the MedTech side of the business, where the company has been focusing more attention after its divestiture efforts. Ophthalmology is a major procedure-driven segment, and intraocular lenses are a core tool in cataract surgery, one of the most common surgical interventions globally. New product data in this area can influence how surgeons choose between competing lens options. The TECNIS PureSee results around patient satisfaction, spectacle independence, and vision metrics provide additional context on how t
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- The Smartest Dividend Stocks to Buy With $2,000 Right Now [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Could This Healthcare Stock Help Make You Rich Over the Next Decade? [Yahoo! Finance]Yahoo! Finance
- Notable analyst calls this week: Tesla, Qualcomm and Biogen among top picks [Seeking Alpha]Seeking Alpha
- Is Johnson & Johnson a Buy After Its Q1 2026 Earnings Report? [Yahoo! Finance]Yahoo! Finance
- US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/14/26 - Beat
JNJ
Sec Filings
- 4/14/26 - Form 8-K
- 3/26/26 - Form SCHEDULE
- 3/18/26 - Form 13F-HR/A
- JNJ's page on the SEC website